AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
GABAPENTIN 300.000 Mg ;
9 registrations across 1 African market— 9 active
Markets with GABAPENTIN 300.000 Mg ;
Recent registrations
| Brand / Product | Market | Holder | Status | Expires |
|---|---|---|---|---|
| Shalgaten 300 mg Hard Gelatin Capsules | 🇪🇬Egypt | Mash tech for pharmaceutical industries - local under construction | active | — |
| Gabimash 300MG Tablets | 🇪🇬Egypt | Bio Med For Pharmaceutical Industries (BIOMED) | active | — |
| GABAPENTIN 300mg Hard Gelatin Capsules | 🇪🇬Egypt | universal pharmaceutical industries (unipharma) | active | — |
| Shalgaten 300 mg Hard Gelatin Capsules | 🇪🇬Egypt | Mash tech for pharmaceutical industries - local under construction | active | — |
| GABAPENTIN 300mg Hard Gelatin Capsules | 🇪🇬Egypt | universal pharmaceutical industries (unipharma) | active | — |
| NEURONTIN 300mg Hard Gelatin Capsules | 🇪🇬Egypt | Viatris Egypt | active | — |
| Gralipentin 300 mg Extended Release Film Coated Tablets | 🇪🇬Egypt | ATCO Pharma for Pharmaceutical Industries | active | — |
| Gralipentin 300 mg Extended Release Film Coated Tablets | 🇪🇬Egypt | ATCO Pharma for Pharmaceutical Industries | active | — |
| Gabimash 300MG Tablets | 🇪🇬Egypt | Bio Med For Pharmaceutical Industries (BIOMED) | active | — |
GABAPENTIN 300.000 Mg ; in Africa — Regulatory Overview
GABAPENTIN 300.000 Mg ; is registered across 1 African markets with 9 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including Egypt. AfricaRegulatory refreshes this data daily from official government sources.
Of the 9 registrations, 9 (100%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.